Pharmaceutical and Therapeutics Committee
The Medicaid P & T Committee is comprised of up to 15 actively practicing healthcare professionals appointed by the Secretary of DHHR and acts in an advisory capacity to assist BMS in selecting drugs for the Preferred Drug List. Members may serve a maximum of three, three-year terms. Members are required to disclose their conflicts of interest, if any, and to maintain confidentiality of drug rebate information. The Committee meets three times per year and as necessary to review the PDL and new drugs as they become available.
Meeting Agendas and Minutes: